Table of Content

1 Market Overview of Parkinson Disease Drug
1.1 Parkinson Disease Drug Market Overview
1.1.1 Parkinson Disease Drug Product Scope
1.1.2 Parkinson Disease Drug Market Status and Outlook
1.2 Global Parkinson Disease Drug Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Parkinson Disease Drug Market Size by Region (2018-2034)
1.4 Global Parkinson Disease Drug Historic Market Size by Region (2018-2024)
1.5 Global Parkinson Disease Drug Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Parkinson Disease Drug Market Size (2018-2034)
1.6.1 North America Parkinson Disease Drug Market Size (2018-2034)
1.6.2 Europe Parkinson Disease Drug Market Size (2018-2034)
1.6.3 Asia-Pacific Parkinson Disease Drug Market Size (2018-2034)
1.6.4 Latin America Parkinson Disease Drug Market Size (2018-2034)
1.6.5 Middle East & Africa Parkinson Disease Drug Market Size (2018-2034)
2 Parkinson Disease Drug Market by Type
2.1 Introduction
2.1.1 Sinemet-CR
2.1.2 Trastal
2.1.3 Madopar
2.1.4 COMT Inhibitor
2.1.5 Other
2.2 Global Parkinson Disease Drug Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Parkinson Disease Drug Historic Market Size by Type (2018-2024)
2.2.2 Global Parkinson Disease Drug Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Parkinson Disease Drug Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Parkinson Disease Drug Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Parkinson Disease Drug Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Parkinson Disease Drug Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Parkinson Disease Drug Revenue Breakdown by Type (2018-2034)
3 Parkinson Disease Drug Market Overview by Application
3.1 Introduction
3.1.1 Under 40 Years Old
3.1.2 40-65 Years Old
3.1.3 Above 65 Years Old
3.2 Global Parkinson Disease Drug Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Parkinson Disease Drug Historic Market Size by Application (2018-2024)
3.2.2 Global Parkinson Disease Drug Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Parkinson Disease Drug Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Parkinson Disease Drug Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Parkinson Disease Drug Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Parkinson Disease Drug Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Parkinson Disease Drug Revenue Breakdown by Application (2018-2034)
4 Parkinson Disease Drug Competition Analysis by Players
4.1 Global Parkinson Disease Drug Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinson Disease Drug as of 2022)
4.3 Date of Key Players Enter into Parkinson Disease Drug Market
4.4 Global Top Players Parkinson Disease Drug Headquarters and Area Served
4.5 Key Players Parkinson Disease Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Parkinson Disease Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck
5.1.1 Merck Profile
5.1.2 Merck Main Business
5.1.3 Merck Parkinson Disease Drug Products, Services and Solutions
5.1.4 Merck Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.1.5 Merck Recent Developments
5.2 Akorn
5.2.1 Akorn Profile
5.2.2 Akorn Main Business
5.2.3 Akorn Parkinson Disease Drug Products, Services and Solutions
5.2.4 Akorn Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.2.5 Akorn Recent Developments
5.3 GSK
5.3.1 GSK Profile
5.3.2 GSK Main Business
5.3.3 GSK Parkinson Disease Drug Products, Services and Solutions
5.3.4 GSK Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.3.5 Novartis Recent Developments
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business
5.4.3 Novartis Parkinson Disease Drug Products, Services and Solutions
5.4.4 Novartis Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.4.5 Novartis Recent Developments
5.5 Boehringer Ingelheim
5.5.1 Boehringer Ingelheim Profile
5.5.2 Boehringer Ingelheim Main Business
5.5.3 Boehringer Ingelheim Parkinson Disease Drug Products, Services and Solutions
5.5.4 Boehringer Ingelheim Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.5.5 Boehringer Ingelheim Recent Developments
5.6 Teva Pharmaceutical
5.6.1 Teva Pharmaceutical Profile
5.6.2 Teva Pharmaceutical Main Business
5.6.3 Teva Pharmaceutical Parkinson Disease Drug Products, Services and Solutions
5.6.4 Teva Pharmaceutical Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.6.5 Teva Pharmaceutical Recent Developments
5.7 Abbvie
5.7.1 Abbvie Profile
5.7.2 Abbvie Main Business
5.7.3 Abbvie Parkinson Disease Drug Products, Services and Solutions
5.7.4 Abbvie Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.7.5 Abbvie Recent Developments
5.8 Kyowa Hakko Kirin Pharma
5.8.1 Kyowa Hakko Kirin Pharma Profile
5.8.2 Kyowa Hakko Kirin Pharma Main Business
5.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Products, Services and Solutions
5.8.4 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.8.5 Kyowa Hakko Kirin Pharma Recent Developments
5.9 Astellas Pharma
5.9.1 Astellas Pharma Profile
5.9.2 Astellas Pharma Main Business
5.9.3 Astellas Pharma Parkinson Disease Drug Products, Services and Solutions
5.9.4 Astellas Pharma Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.9.5 Astellas Pharma Recent Developments
5.10 Desitin Arzneimittel
5.10.1 Desitin Arzneimittel Profile
5.10.2 Desitin Arzneimittel Main Business
5.10.3 Desitin Arzneimittel Parkinson Disease Drug Products, Services and Solutions
5.10.4 Desitin Arzneimittel Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.10.5 Desitin Arzneimittel Recent Developments
5.11 Endo Pharmaceuticals
5.11.1 Endo Pharmaceuticals Profile
5.11.2 Endo Pharmaceuticals Main Business
5.11.3 Endo Pharmaceuticals Parkinson Disease Drug Products, Services and Solutions
5.11.4 Endo Pharmaceuticals Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.11.5 Endo Pharmaceuticals Recent Developments
5.12 F.Hoffmann-La Roche
5.12.1 F.Hoffmann-La Roche Profile
5.12.2 F.Hoffmann-La Roche Main Business
5.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Products, Services and Solutions
5.12.4 F.Hoffmann-La Roche Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.12.5 F.Hoffmann-La Roche Recent Developments
5.13 H.Lundbeck
5.13.1 H.Lundbeck Profile
5.13.2 H.Lundbeck Main Business
5.13.3 H.Lundbeck Parkinson Disease Drug Products, Services and Solutions
5.13.4 H.Lundbeck Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.13.5 H.Lundbeck Recent Developments
5.14 Valeant
5.14.1 Valeant Profile
5.14.2 Valeant Main Business
5.14.3 Valeant Parkinson Disease Drug Products, Services and Solutions
5.14.4 Valeant Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.14.5 Valeant Recent Developments
5.15 Apokyn
5.15.1 Apokyn Profile
5.15.2 Apokyn Main Business
5.15.3 Apokyn Parkinson Disease Drug Products, Services and Solutions
5.15.4 Apokyn Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.15.5 Apokyn Recent Developments
5.16 Orion
5.16.1 Orion Profile
5.16.2 Orion Main Business
5.16.3 Orion Parkinson Disease Drug Products, Services and Solutions
5.16.4 Orion Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.16.5 Orion Recent Developments
5.17 Stada Arzneimittel
5.17.1 Stada Arzneimittel Profile
5.17.2 Stada Arzneimittel Main Business
5.17.3 Stada Arzneimittel Parkinson Disease Drug Products, Services and Solutions
5.17.4 Stada Arzneimittel Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.17.5 Stada Arzneimittel Recent Developments
5.18 US WorldMeds
5.18.1 US WorldMeds Profile
5.18.2 US WorldMeds Main Business
5.18.3 US WorldMeds Parkinson Disease Drug Products, Services and Solutions
5.18.4 US WorldMeds Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.18.5 US WorldMeds Recent Developments
5.19 Bausch Health
5.19.1 Bausch Health Profile
5.19.2 Bausch Health Main Business
5.19.3 Bausch Health Parkinson Disease Drug Products, Services and Solutions
5.19.4 Bausch Health Parkinson Disease Drug Revenue (US$ Million) & (2018-2024)
5.19.5 Bausch Health Recent Developments
6 North America
6.1 North America Parkinson Disease Drug Market Size by Country (2018-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Parkinson Disease Drug Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Parkinson Disease Drug Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Parkinson Disease Drug Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Parkinson Disease Drug Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Parkinson Disease Drug Market Dynamics
11.1 Parkinson Disease Drug Industry Trends
11.2 Parkinson Disease Drug Market Drivers
11.3 Parkinson Disease Drug Market Challenges
11.4 Parkinson Disease Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Parkinson Disease Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Parkinson Disease Drug Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Parkinson Disease Drug Market Size Share by Region (2018-2024)
Table 4. Global Parkinson Disease Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Parkinson Disease Drug Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Parkinson Disease Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Parkinson Disease Drug Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Parkinson Disease Drug Revenue Market Share by Type (2018-2024)
Table 9. Global Parkinson Disease Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Parkinson Disease Drug Revenue Market Share by Type (2024-2034)
Table 11. North America Parkinson Disease Drug Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Parkinson Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Parkinson Disease Drug Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Parkinson Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Parkinson Disease Drug Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Parkinson Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Parkinson Disease Drug Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Parkinson Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Parkinson Disease Drug Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Parkinson Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Parkinson Disease Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Parkinson Disease Drug Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Parkinson Disease Drug Revenue Market Share by Application (2018-2024)
Table 24. Global Parkinson Disease Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Parkinson Disease Drug Revenue Market Share by Application (2024-2034)
Table 26. North America Parkinson Disease Drug Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Parkinson Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Parkinson Disease Drug Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Parkinson Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Parkinson Disease Drug Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Parkinson Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Parkinson Disease Drug Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Parkinson Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Parkinson Disease Drug Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Parkinson Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Parkinson Disease Drug Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Parkinson Disease Drug Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinson Disease Drug as of 2022)
Table 39. Date of Key Players Enter into Parkinson Disease Drug Market
Table 40. Global Parkinson Disease Drug Key Players Headquarters and Area Served
Table 41. Parkinson Disease Drug Product Solution and Service
Table 42. Global Parkinson Disease Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Merck Basic Information List
Table 45. Merck Description and Business Overview
Table 46. Merck Parkinson Disease Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Parkinson Disease Drug Business of Merck (2018-2024)
Table 48. Merck Recent Developments
Table 49. Akorn Basic Information List
Table 50. Akorn Description and Business Overview
Table 51. Akorn Parkinson Disease Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Parkinson Disease Drug Business of Akorn (2018-2024)
Table 53. Akorn Recent Developments
Table 54. GSK Basic Information List
Table 55. GSK Description and Business Overview
Table 56. GSK Parkinson Disease Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Parkinson Disease Drug Business of GSK (2018-2024)
Table 58. GSK Recent Developments
Table 59. Novartis Basic Information List
Table 60. Novartis Description and Business Overview
Table 61. Novartis Parkinson Disease Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Parkinson Disease Drug Business of Novartis (2018-2024)
Table 63. Novartis Recent Developments
Table 64. Boehringer Ingelheim Basic Information List
Table 65. Boehringer Ingelheim Description and Business Overview
Table 66. Boehringer Ingelheim Parkinson Disease Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Parkinson Disease Drug Business of Boehringer Ingelheim (2018-2024)
Table 68. Boehringer Ingelheim Recent Developments
Table 69. Teva Pharmaceutical Basic Information List
Table 70. Teva Pharmaceutical Description and Business Overview
Table 71. Teva Pharmaceutical Parkinson Disease Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Parkinson Disease Drug Business of Teva Pharmaceutical (2018-2024)
Table 73. Teva Pharmaceutical Recent Developments
Table 74. Abbvie Basic Information List
Table 75. Abbvie Description and Business Overview
Table 76. Abbvie Parkinson Disease Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Parkinson Disease Drug Business of Abbvie (2018-2024)
Table 78. Abbvie Recent Developments
Table 79. Kyowa Hakko Kirin Pharma Basic Information List
Table 80. Kyowa Hakko Kirin Pharma Description and Business Overview
Table 81. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Parkinson Disease Drug Business of Kyowa Hakko Kirin Pharma (2018-2024)
Table 83. Kyowa Hakko Kirin Pharma Recent Developments
Table 84. Astellas Pharma Basic Information List
Table 85. Astellas Pharma Description and Business Overview
Table 86. Astellas Pharma Parkinson Disease Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Parkinson Disease Drug Business of Astellas Pharma (2018-2024)
Table 88. Astellas Pharma Recent Developments
Table 89. Desitin Arzneimittel Basic Information List
Table 90. Desitin Arzneimittel Description and Business Overview
Table 91. Desitin Arzneimittel Parkinson Disease Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Parkinson Disease Drug Business of Desitin Arzneimittel (2018-2024)
Table 93. Desitin Arzneimittel Recent Developments
Table 94. Endo Pharmaceuticals Basic Information List
Table 95. Endo Pharmaceuticals Description and Business Overview
Table 96. Endo Pharmaceuticals Parkinson Disease Drug Products, Services and Solutions
Table 97. Revenue (US$ Million) in Parkinson Disease Drug Business of Endo Pharmaceuticals (2018-2024)
Table 98. Endo Pharmaceuticals Recent Developments
Table 99. F.Hoffmann-La Roche Basic Information List
Table 100. F.Hoffmann-La Roche Description and Business Overview
Table 101. F.Hoffmann-La Roche Parkinson Disease Drug Products, Services and Solutions
Table 102. Revenue (US$ Million) in Parkinson Disease Drug Business of F.Hoffmann-La Roche (2018-2024)
Table 103. F.Hoffmann-La Roche Recent Developments
Table 104. H.Lundbeck Basic Information List
Table 105. H.Lundbeck Description and Business Overview
Table 106. H.Lundbeck Parkinson Disease Drug Products, Services and Solutions
Table 107. Revenue (US$ Million) in Parkinson Disease Drug Business of H.Lundbeck (2018-2024)
Table 108. H.Lundbeck Recent Developments
Table 109. Valeant Basic Information List
Table 110. Valeant Description and Business Overview
Table 111. Valeant Parkinson Disease Drug Products, Services and Solutions
Table 112. Revenue (US$ Million) in Parkinson Disease Drug Business of Valeant (2018-2024)
Table 113. Valeant Recent Developments
Table 114. Apokyn Basic Information List
Table 115. Apokyn Description and Business Overview
Table 116. Apokyn Parkinson Disease Drug Products, Services and Solutions
Table 117. Revenue (US$ Million) in Parkinson Disease Drug Business of Apokyn (2018-2024)
Table 118. Apokyn Recent Developments
Table 119. Orion Basic Information List
Table 120. Orion Description and Business Overview
Table 121. Orion Parkinson Disease Drug Products, Services and Solutions
Table 122. Revenue (US$ Million) in Parkinson Disease Drug Business of Orion (2018-2024)
Table 123. Orion Recent Developments
Table 124. Stada Arzneimittel Basic Information List
Table 125. Stada Arzneimittel Description and Business Overview
Table 126. Stada Arzneimittel Parkinson Disease Drug Products, Services and Solutions
Table 127. Revenue (US$ Million) in Parkinson Disease Drug Business of Stada Arzneimittel (2018-2024)
Table 128. Stada Arzneimittel Recent Developments
Table 129. US WorldMeds Basic Information List
Table 130. US WorldMeds Description and Business Overview
Table 131. US WorldMeds Parkinson Disease Drug Products, Services and Solutions
Table 132. Revenue (US$ Million) in Parkinson Disease Drug Business of US WorldMeds (2018-2024)
Table 133. US WorldMeds Recent Developments
Table 134. Bausch Health Basic Information List
Table 135. Bausch Health Description and Business Overview
Table 136. Bausch Health Parkinson Disease Drug Products, Services and Solutions
Table 137. Revenue (US$ Million) in Parkinson Disease Drug Business of Bausch Health (2018-2024)
Table 138. Bausch Health Recent Developments
Table 139. North America Parkinson Disease Drug Market Size by Country (2018-2024) & (US$ Million)
Table 140. North America Parkinson Disease Drug Market Size by Country (2024-2034) & (US$ Million)
Table 141. Europe Parkinson Disease Drug Market Size by Country (2018-2024) & (US$ Million)
Table 142. Europe Parkinson Disease Drug Market Size by Country (2024-2034) & (US$ Million)
Table 143. Asia-Pacific Parkinson Disease Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 144. Asia-Pacific Parkinson Disease Drug Market Size by Region (2018-2024) & (US$ Million)
Table 145. Asia-Pacific Parkinson Disease Drug Market Size by Region (2024-2034) & (US$ Million)
Table 146. Asia-Pacific Parkinson Disease Drug Market Share by Region (2018-2024)
Table 147. Asia-Pacific Parkinson Disease Drug Market Share by Region (2024-2034)
Table 148. Latin America Parkinson Disease Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 149. Latin America Parkinson Disease Drug Market Size by Country (2018-2024) & (US$ Million)
Table 150. Latin America Parkinson Disease Drug Market Size by Country (2024-2034) & (US$ Million)
Table 151. Middle East & Africa Parkinson Disease Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 152. Middle East & Africa Parkinson Disease Drug Market Size by Country (2018-2024) & (US$ Million)
Table 153. Middle East & Africa Parkinson Disease Drug Market Size by Country (2024-2034) & (US$ Million)
Table 154. Parkinson Disease Drug Market Trends
Table 155. Parkinson Disease Drug Market Drivers
Table 156. Parkinson Disease Drug Market Challenges
Table 157. Parkinson Disease Drug Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson Disease Drug Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Parkinson Disease Drug Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Parkinson Disease Drug Market Share by Regions: 2022 VS 2034
Figure 4. Global Parkinson Disease Drug Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Parkinson Disease Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Parkinson Disease Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Parkinson Disease Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Parkinson Disease Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Parkinson Disease Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of Sinemet-CR
Figure 11. Global Sinemet-CR Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of Trastal
Figure 13. Global Trastal Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of Madopar
Figure 15. Global Madopar Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Product Picture of COMT Inhibitor
Figure 17. Global COMT Inhibitor Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 18. Product Picture of Other
Figure 19. Global Other Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 20. Global Parkinson Disease Drug Market Size Share by Type: 2022 & 2034
Figure 21. North America Parkinson Disease Drug Revenue Market Share by Type (2018-2034)
Figure 22. Europe Parkinson Disease Drug Revenue Market Share by Type (2018-2034)
Figure 23. Asia-Pacific Parkinson Disease Drug Revenue Market Share by Type (2018-2034)
Figure 24. Latin America Parkinson Disease Drug Revenue Market Share by Type (2018-2034)
Figure 25. Middle East and Africa Parkinson Disease Drug Revenue Market Share by Type (2018-2034)
Figure 26. Under 40 Years Old Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 27. 40-65 Years Old Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 28. Above 65 Years Old Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 29. Global Parkinson Disease Drug Market Size Share by Application: 2022 & 2034
Figure 30. North America Parkinson Disease Drug Revenue Market Share by Application (2018-2034)
Figure 31. Europe Parkinson Disease Drug Revenue Market Share by Application (2018-2034)
Figure 32. Asia-Pacific Parkinson Disease Drug Revenue Market Share by Application (2018-2034)
Figure 33. Latin America Parkinson Disease Drug Revenue Market Share by Application (2018-2034)
Figure 34. Middle East and Africa Parkinson Disease Drug Revenue Market Share by Application (2018-2034)
Figure 35. Parkinson Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 36. Global Top 5 and Top 10 Players Parkinson Disease Drug Market Share in 2022
Figure 37. North America Parkinson Disease Drug Market Share by Country (2018-2034)
Figure 38. U.S. Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 39. Canada Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 40. Germany Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 41. France Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 42. U.K. Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 43. Italy Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 44. Russia Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 45. Nordic Countries Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 46. Asia-Pacific Parkinson Disease Drug Market Share by Region (2018-2034)
Figure 47. China Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 48. Japan Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 49. South Korea Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 50. Southeast Asia Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 51. India Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 52. Australia Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 53. Latin America Parkinson Disease Drug Market Share by Country (2018-2034)
Figure 54. Mexico Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 55. Brazil Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 56. Middle East & Africa Parkinson Disease Drug Market Share by Country (2018-2034)
Figure 57. Turkey Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 58. Saudi Arabia Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 59. UAE Parkinson Disease Drug Market Size (2018-2034) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report